These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 10052899
1. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. Coquet L, Junter GA, Jouenne T. J Antimicrob Chemother; 1998 Dec; 42(6):755-60. PubMed ID: 10052899 [Abstract] [Full Text] [Related]
4. The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics. Tresse O, Jouenne T, Junter GA. J Antimicrob Chemother; 1995 Sep; 36(3):521-6. PubMed ID: 8830016 [Abstract] [Full Text] [Related]
5. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa]. Thabaut A, Meyran M. Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428 [Abstract] [Full Text] [Related]
8. In Vitro Evaluation of Biofilm Dispersal as a Therapeutic Strategy To Restore Antimicrobial Efficacy. Roizman D, Vidaillac C, Givskov M, Yang L. Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760898 [Abstract] [Full Text] [Related]
11. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials. Iaconis JP, Pitkin DH, Sheikh W, Nadler HL. Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693 [Abstract] [Full Text] [Related]
12. Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Todisco T, Eslami A, Baglioni S, Sposini T, Tascini C, Sommer E, Knoch M. J Aerosol Med; 2000 Feb; 13(1):11-6. PubMed ID: 10947319 [Abstract] [Full Text] [Related]
14. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. Díez-Aguilar M, Morosini MI, Köksal E, Oliver A, Ekkelenkamp M, Cantón R. Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746 [Abstract] [Full Text] [Related]
16. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years]. Nasu Y, Abe M, Ono N, Araki M, Horimi T, Takahashi I. Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905 [Abstract] [Full Text] [Related]